Issue

Vol. 36 No. 6 (2024): Vol 36 Issue 6, 2024

Copyright (c) 2024 Sneha Thakur

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Formulation of Novel Boswellic Acid Loaded-PEGlyated Nanoparticles and Effect on SARS COVID 19 Virus: in silico Docking Analysis and ADMET Studies

https://doi.org/10.14233/ajchem.2024.31226
Sneha Thakur
Department of Pharmacognosy, St. Pauls College of Pharmacy, Turkayamjal-501510, India
https://orcid.org/0000-0003-3950-1702
M. Kiranmai
Department of Pharmaceutical Chemistry, St. Pauls College of Pharmacy, Turkayamjal-501510, India
https://orcid.org/0000-0002-7487-2237

Corresponding Author(s) : Sneha Thakur

snehathakur2189@gmail.com

Asian Journal of Chemistry, Vol. 36 No. 6 (2024): Vol 36 Issue 6, 2024

Abstract

SARS COVID-19 virus is serious threats to the mankind changing its virulence. The pandemic emergence resulted in the change of health care scenario since its outbreak and suggested the inclusion of molecular modeling and combinatorial chemistry process that hastens the drug discovery process resulting in screening of large number of compounds for the therapeutic target proposed. The studies revealed that the boswellic acid (pentacyclic triterpenoid) obtained from gum resin of Boswellia serrata is found to have potential against the SARS covid virus. The present study was conducted to synthesize boswellic acid–PEG from isolated boswellic acid (gum resin of B. serrata) and evaluated the anti-covid potential of boswellic acid by in silico docking studies and toxicity analysis by ADMET Pro. The target protein PDB RNA polymerase (1S76), protease (6LU7), ACE2 (6M0J) were downloaded from RCDB database. The boswellic acid was active against the selected target proteins active for SARS virus entry into the cells and also prevent the viral multiplication. ADMET studies have proved slight endo-carcinogenecity, which increases with dose. Thus, this novel molecule can be developed as lead against the SARS virus by formulating boswellic acid–PEG nanoparticles with sustained release characteristics. As an attempt to develop the drug boswellic acid-PEG nanoparticles with PEG as permeation enhancer for oral drug delivery and characterized using DLS, FTIR, XRD and SEM techniques, which has proven the 253 nm size, stable, highly dispersed, spherical shape without any agglomeration. The drug release studies proved the sustained release nature of the nanoparticles, which leads to reduce dosage. Further, in vivo-in vitro correlation proves the clinical validation for drug discovery process.

Keywords

SARS COVID 19 virus Boswellic acid Nanoparticles in silico Drug release’ ADMET
Thakur, S., & Kiranmai, M. (2024). Formulation of Novel Boswellic Acid Loaded-PEGlyated Nanoparticles and Effect on SARS COVID 19 Virus: in silico Docking Analysis and ADMET Studies. Asian Journal of Chemistry, 36(6), 1409–1416. https://doi.org/10.14233/ajchem.2024.31226
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. Q. Li, China CDC Wkly., 2, 79 (2020); https://doi.org/10.46234/ccdcw2020.022
  2. W. Tan, X. Zhao, X. Ma, W. Wang, P. Niu, W. Xu, G. F. Gao and G. Wu, China CDC Wkly., 2, 61 (2020); https://doi.org/10.46234/ccdcw2020.017
  3. N. Zhu, D. Zhang, W. Wang, X. Li, B. Yang, J. Song, X. Zhao, B. Huang, W. Shi, R. Lu, P. Niu, F. Zhan, X. Ma, D. Wang, W. Xu, G. Wu, G.F. Gao and W. Tan, N. Engl. J. Med., 382, 727 (2020); https://doi.org/10.1056/NEJMoa2001017
  4. N. Xiang, F. Havers, T. Chen, Y. Song, W. Tu, L. Li, Y. Cao, B. Liu, L. Zhou, L. Meng, Z. Hong, R. Wang, Y. Niu, J. Yao, K. Liao, L. Jin, Y. Zhang, Q. Li, M.-A. Widdowson and Z. Feng, Emerg. Infect. Dis., 19, 1784 (2013); https://doi.org/10.3201/eid1911.130865
  5. V.J. Munster, M. Koopmans, N. van Doremalen, D. van Riel and E. de Wit, N. Engl. J. Med., 382, 692 (2020); https://doi.org/10.1056/NEJMp2000929
  6. L. Samavati and B.D. Uhal, Front. Cell. Infect. Microbiol., 10, 317 (2020); https://doi.org/10.3389/fcimb.2020.00317
  7. E.I. Azhar, S.A. El-Kafrawy, S.A. Farraj, A.M. Hassan, M.S. Al-Saeed, A.M. Hashem and T.A. Madani, N. Engl. J. Med., 370, 2499 (2014); https://doi.org/10.1056/NEJMoa1401505
  8. F. Aqil, R. Munagala, J. Jeyabalan and M.V. Vadhanam, Cancer Lett., 334, 133 (2013); https://doi.org/10.1016/j.canlet.2013.02.032
  9. S. Kalepua and V. Nekkanti, Acta Pharm. Sinica B, 5, 442 (2015); https://doi.org/10.1016/j.apsb.2015.07.003
  10. C.T. Bauch, J.O. Lloyd-Smith, M.P. Coffee and A.P. Galvani, Epidemiology, 16, 791 (2005); https://doi.org/10.1097/01.ede.0000181633.80269.4c
  11. Y. Liu, Y. Liang, J. Yuhong, P. Xin, J.L. Han, Y. Du, X. Yu, R. Zhu, M. Zhang, W. Chen and Y. Ma, Drug Des. Devel. Ther., 18, 1469 (2024); https://doi.org/10.2147/DDDT.S447496
  12. S. Perlman, N. Engl. J. Med., 382, 760 (2020); https://doi.org/10.1056/NEJMe2001126
  13. W. Sungnak, N. Huang, C. Bécavin, M. Berg, M. Litvinukova, R. Queen, C. Talavera-López, H. Maatz, D. Reichart, F. Sampaziotis, K.B. Worlock, M. Yoshida and J.L. Barnes, Nat. Med., 26, 681 (2020); https://doi.org/10.1038/s41591-020-0868-6
  14. K. Reising, J. Meins, B. Bastian, G. Eckert, W.E. Mueller, M. Schubert-Zsilavecz and M. Abdel-Tawab, Anal. Chem., 77, 6640 (2005); https://doi.org/10.1021/ac0506478
  15. A.S. Shah, S.I. Rathod, N.B. Suhagia, S.S. Pandya and V.K. Parmar, J. Chromatogr. Sci., 46, 735 (2008); https://doi.org/10.1093/chromsci/46.8.735
  16. A. Frank and M. Unger, J. Chromatogr. A, 1112, 255 (2006); https://doi.org/10.1016/j.chroma.2005.11.116
  17. N.K. Roy, D. Parama, K. Banik, D. Bordoloi, A.K. Devi, K.K. Thakur, G. Padmavathi, M. Shakibaei, L. Fan, G. Sethi and A.B. Kunnumakkara, Int. J. Mol. Sci., 20, 4101 (2019); https://doi.org/10.3390/ijms20174101
  18. L.M. Ensign, C. Schneider, J.S. Suk, R. Cone and J. Hanes, Adv. Mater., 24, 3887 (2012); https://doi.org/10.1002/adma.201201800
  19. S. Gaspani and B. Milani, GaBi J., 2, 60 (2013); https://doi.org/10.5639/gabij.2013.0202.022
  20. J. Grießinger, S. Dünnhaupt, B. Cattoz, P. Griffiths, S. Oh, S.B. Gómez, M. Wilcox, J. Pearson, M. Gumbleton, M. Abdulkarim, I.P. de Sousa and A. Bernkop-Schnürch, Eur. J. Pharm. Biopharm., 96, 464 (2015); https://doi.org/10.1016/j.ejpb.2015.01.005
  21. S. Gurunathan, M.H. Kang, M. Qasim and J.H. Kim, Int. J. Mol. Sci., 19, 3264 (2018); https://doi.org/10.3390/ijms19103264
  22. S. Hua, M.B.C. de Matos, J.M. Metselaar and G. Storm, Front. Pharmacol., 9, 790 (2018); https://doi.org/10.3389/fphar.2018.00790
  23. L. Inchaurraga, N. Martín-Arbella, V. Zabaleta, G. Quincoces, I. Peñuelas and J.M. Irache, Eur. J. Pharm. Biopharm., 97, 280 (2015); https://doi.org/10.1016/j.ejpb.2014.12.021
  24. L. Inchaurraga, A.L. Martínez-López, N. Martin-Arbella and J.M. Irache, Drug Deliv. Transl. Res., 10, 1601 (2020); https://doi.org/10.1007/s13346-020-00796-3
  25. S. Thakur and G.K. Mohan, BioNanoSci., 12, 670 (2022); https://doi.org/10.1007/s12668-022-00962-6
  26. F. Laffleur, F. Hintzen, G. Shahnaz, D. Rahmat, K. Leithner and A. Bernkop-Schnürch, Nanomedicine, 9, 387 (2014); https://doi.org/10.2217/nnm.13.26
  27. G.M. Morris, R. Huey, W. Lindstrom, M.F. Sanner, R.K. Belew, D.S. Goodsell and A.J. Olson, J. Comput. Chem., 30, 2785 (2009); https://doi.org/10.1002/jcc.21256
  28. F. Cheng, W. Li, Y. Zhou, J. Shen, Z. Wu, G. Liu, P.W. Lee and Y. Tang, J. Chem. Inf. Model., 52, 3099 (2012); https://doi.org/10.1021/ci300367a
  29. M.N. Drwal, P. Banerjee, M. Dunkel, M.R. Wettig and R. Preissner, Nucleic Acids Res., 42, W53 (2014); https://doi.org/10.1093/nar/gku401
  30. A.A. D’souza and R. Shegokar, Expert Opin. Drug Deliv., 13, 1257 (2016); https://doi.org/10.1080/17425247.2016.1182485
  31. S. Doktorovova, R. Shegokar, P. Martins-Lopes, A.M. Silva, C.M. Lopes, R.H. Müller and E.B. Souto, Eur. J. Pharm. Sci., 45, 606 (2012); https://doi.org/10.1016/j.ejps.2011.12.016
  32. A. Kumar, S. Sharma, S. Mishra, S. Ojha and P. Upadhyay, Anti-cancer Agents Med. Chem., 23, 1499 (2023); https://doi.org/10.2174/1871520623666230417080437
  33. O. Pechanova, A. Barta, M. Koneracka, V. Zavisova, M. Kubovcikova, J. Klimentova, J. Torok, A. Zemancikov and M. Cebova, Molecules, 24, 2710 (2019); https://doi.org/10.3390/molecules24152710
  34. S. Al-Zahrani, S. Astudillo-Calderón, B. Pintos, R. Pérez-Urria, J.A. Manzanera, L. Martín and A. Gomez-Garay, Plants, 10, 1671 (2021); https://doi.org/10.3390/plants10081671
  35. A.Z.M. Fahim, M.S. Ghouse, S.Q. Islam, M.A.M. Danish, S. Mehmood, S. Saniya and Q.I. Fatima, Asian J. Pharm. Anal., 11, 98 (2021); https://doi.org/10.52711/2231-5675.2021.00018
  36. K. Maisel, M. Reddy, Q. Xu, S. Chattopadhyay, R. Cone, L.M. Ensign and J. Hanes, Nanomedicine, 11, 1337 (2016); https://doi.org/10.2217/nnm-2016-0047
  37. S.S. D’Souza and P.P. DeLuca, Pharm. Res., 23, 460 (2006); https://doi.org/10.1007/s11095-005-9397-8
  38. S. Modi and B.D. Anderson, Mol. Pharm., 10, 3076 (2013); https://doi.org/10.1021/mp400154a
  39. M. Yu, W. Yuan, D. Li, A. Schwendeman and S.P. Schwendeman, J. Control. Release, 315, 23 (2019); https://doi.org/10.1016/j.jconrel.2019.09.016
  40. Y. Zambito, E. Pedreschi and G. Di Colo, Int. J. Pharm., 434, 28 (2012); https://doi.org/10.1016/j.ijpharm.2012.05.020
  41. M. Cetin, A. Atila and Y. Kadioglu, AAPS PharmSciTech, 11, 1250 (2010); https://doi.org/10.1208/s12249-010-9489-6
  42. J. Liu, D.A. Sonshine, S. Shervani and R.H. Hurt, ACS Nano, 4, 6903 (2010); https://doi.org/10.1021/nn102272n
Read More
Author biographies is not available.
Statistic
Read Counter : 0 Download : 0